TD Asset Management Inc reduced its holdings in shares of Masimo Corporation (NASDAQ:MASI – Free Report) by 35.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 107,858 shares of the medical equipment provider’s stock after selling 59,318 shares during the period. TD Asset Management Inc owned about 0.20% of Masimo worth $15,914,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in the business. MAI Capital Management boosted its stake in shares of Masimo by 176.7% in the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 129 shares during the period. Smartleaf Asset Management LLC lifted its stake in Masimo by 80.0% in the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 136 shares during the last quarter. Allworth Financial LP grew its holdings in Masimo by 72.8% during the 2nd quarter. Allworth Financial LP now owns 387 shares of the medical equipment provider’s stock worth $65,000 after acquiring an additional 163 shares in the last quarter. Clearstead Advisors LLC grew its holdings in Masimo by 18.4% during the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $69,000 after acquiring an additional 73 shares in the last quarter. Finally, Hantz Financial Services Inc. increased its position in shares of Masimo by 792.3% in the 3rd quarter. Hantz Financial Services Inc. now owns 580 shares of the medical equipment provider’s stock valued at $86,000 after purchasing an additional 515 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.
Masimo Stock Performance
NASDAQ MASI opened at $175.35 on Monday. The stock has a market capitalization of $9.42 billion, a price-to-earnings ratio of -16.64, a PEG ratio of 1.78 and a beta of 1.21. The business’s 50 day moving average is $143.09 and its two-hundred day moving average is $143.94. Masimo Corporation has a 12-month low of $125.94 and a 12-month high of $194.88. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69.
Analyst Ratings Changes
Check Out Our Latest Report on Masimo
Masimo Company Profile
Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.
In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.
Featured Articles
- Five stocks we like better than Masimo
- America’s 1776 happening again
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Gilder: Don’t Buy AI Stocks, Do This Instead
- The Biggest IPO Ever… Open to Everyday Folks
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.
